# Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular Disease

> **NCT05826821** · — · COMPLETED · sponsor: **Manchester University NHS Foundation Trust** · enrollment: 107 (actual)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT05826821
- **Lead sponsor:** Manchester University NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-02
- **Primary completion:** 2019-11-29
- **Final completion:** 2020-04-29
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05826821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05826821, "Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05826821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*